Panel Detail

Sunday, September 9, 2012
9:40 AM - 10:30 AM

Who Pays for Treatment and Cures?


Gary Gottlieb, President and CEO, Partners Healthcare
Michael Leavitt, Founder and Chairman, Leavitt Partners; formerly Administrator, Environmental Protection Agency; Secretary of Health and Human Services; and Governor of Utah
Mark McClellan, Senior Fellow, Director, Engelberg Center for Health Care Reform, Brookings Institution; former Administrator, Centers for Medicare and Medicaid Services
Simon Stevens, President, Global Health, UnitedHealth Group


Thomas Priselac, President and CEO, Cedars-Sinai Health System
Even if we are successful at getting new treatments through the research, development and approval process, the question remains whether payers, including the federal government, will be willing - and able - to pick up the tab for them. This panel examines how the Centers for Medicare and Medicaid Services (CMS), hospitals, insurance companies and benefits providers are adapting to meet the new demands of the health care delivery system. It will look at how legislation and government regulations affect private-sector policies. What role are insurance coverage decisions - and insurers themselves - playing farther upstream in the R&D and investment process? And, as these policies are being implemented, how will it impact the way we deliver care and the path toward treatments and cures?

Panel Video


Click image above to play video